<VariationArchive RecordType="classified" VariationID="916027" VariationName="NM_001429.4(EP300):c.3905dup (p.Glu1303fs)" VariationType="Duplication" Accession="VCV000916027" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2020-06-07" MostRecentSubmission="2020-06-07">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="904252" VariationID="916027">
      <GeneList>
        <Gene Symbol="EP300" FullName="E1A binding protein p300" GeneID="2033" HGNC_ID="HGNC:3373" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>22q13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="41092592" stop="41180077" display_start="41092592" display_stop="41180077" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="41488613" stop="41576080" display_start="41488613" display_stop="41576080" Strand="+" />
          </Location>
          <OMIM>602700</OMIM>
          <Haploinsufficiency last_evaluated="2013-03-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=EP300">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2013-03-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=EP300">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001429.4(EP300):c.3905dup (p.Glu1303fs)</Name>
      <CanonicalSPDI>NC_000022.11:41168478:T:TT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>22q13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="22" Accession="NC_000022.11" start="41168478" stop="41168479" display_start="41168478" display_stop="41168479" variantLength="1" positionVCF="41168478" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="22" Accession="NC_000022.10" start="41564482" stop="41564483" display_start="41564482" display_stop="41564483" variantLength="1" positionVCF="41564482" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
      </Location>
      <ProteinChange>E1303fs</ProteinChange>
      <ProteinChange>E1277fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.10" sequenceAccession="NC_000022" sequenceVersion="10" change="g.41564483dup" Assembly="GRCh37">
            <Expression>NC_000022.10:g.41564483dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000022.11" sequenceAccession="NC_000022" sequenceVersion="11" change="g.41168479dup" Assembly="GRCh38">
            <Expression>NC_000022.11:g.41168479dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009817.1" sequenceAccession="NG_009817" sequenceVersion="1" change="g.80870dup">
            <Expression>NG_009817.1:g.80870dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001362843.2" sequenceAccession="NM_001362843" sequenceVersion="2" change="c.3827dup">
            <Expression>NM_001362843.2:c.3827dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001349772.1" sequenceAccession="NP_001349772" sequenceVersion="1" change="p.Glu1277fs">
            <Expression>NP_001349772.1:p.Glu1277fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001429.4" sequenceAccession="NM_001429" sequenceVersion="4" change="c.3905dup" MANESelect="true">
            <Expression>NM_001429.4:c.3905dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001420.2" sequenceAccession="NP_001420" sequenceVersion="2" change="p.Glu1303fs">
            <Expression>NP_001420.2:p.Glu1303fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001429.4" sequenceAccession="NM_001429" sequenceVersion="4" change="c.3905dupT" MANESelect="true">
            <Expression>NM_001429.4:c.3905dupT</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1422" sequenceAccession="LRG_1422">
            <Expression>LRG_1422:g.80870dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1422t1" sequenceAccession="LRG_1422t1">
            <Expression>LRG_1422t1:c.3905dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1422p1" sequenceAccession="LRG_1422p1" change="p.Glu1303fs">
            <Expression>LRG_1422p1:p.Glu1303fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2059152743" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001429.4(EP300):c.3905dup (p.Glu1303fs) AND Rubinstein-Taybi syndrome due to EP300 haploinsufficiency" Accession="RCV001171509" Version="1">
        <ClassifiedConditionList TraitSetID="6729">
          <ClassifiedCondition DB="MedGen" ID="C3150941">Rubinstein-Taybi syndrome due to EP300 haploinsufficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-02-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-02-19" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-06-07" MostRecentSubmission="2020-06-07">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="6729" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="15794" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Rubinstein-Taybi syndrome due to EP300 haploinsufficiency</ElementValue>
                <XRef ID="MONDO:0013364" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Rubinstein-Taybi syndrome 2</ElementValue>
                <XRef ID="Rubinstein-Taybi+syndrome+2/9259" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">EP300</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">RSTS2</ElementValue>
                <XRef Type="MIM" ID="613684" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Rubinstein-Taybi syndrome (RSTS) is characterized by distinctive facial features, broad and often angulated thumbs and halluces, short stature, and moderate-to-severe intellectual disability. The characteristic craniofacial features are downslanted palpebral fissures, low-hanging columella, high palate, grimacing smile, and talon cusps. Prenatal growth is often normal, then height, weight, and head circumference percentiles rapidly drop in the first few months of life. Short stature is typical in adulthood. Obesity may develop in childhood or adolescence. Average IQ ranges between 35 and 50; however, developmental outcome varies considerably. Some individuals with EP300-RSTS have normal intellect. Additional features include ocular abnormalities, hearing loss, respiratory difficulties, congenital heart defects, renal abnormalities, cryptorchidism, feeding problems, recurrent infections, and severe constipation.</Attribute>
                <XRef ID="NBK1526" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301699</ID>
                <ID Source="BookShelf">NBK1526</ID>
              </Citation>
              <XRef ID="353284" DB="Orphanet" />
              <XRef ID="783" DB="Orphanet" />
              <XRef ID="C3150941" DB="MedGen" />
              <XRef ID="MONDO:0013364" DB="MONDO" />
              <XRef Type="MIM" ID="613684" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2637928" SubmissionDate="2020-06-03" DateLastUpdated="2020-06-07" DateCreated="2020-06-07">
        <ClinVarSubmissionID localKey="SUB7334053" submittedAssembly="GRCh37" title="SUB7334053" />
        <ClinVarAccession Accession="SCV001244955" DateUpdated="2020-06-07" DateCreated="2020-06-07" Type="SCV" Version="1" SubmitterName="Institute for Genomic Statistics and Bioinformatics, University Hospital Bonn" OrgID="507028" OrganizationCategory="laboratory" OrgAbbreviation="IGSB" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-02-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The heterozygous insertion of the base thymine at position 41564482 on chromosome 22 was carried out with a coverage of 286 reads and an alternative allele frequency of 0.42 only in the above Patient observed and is thus interpreted as a new mutation. The variant c.3905dupT in exon 24 of the gene EP300 results in a reading frame shift from position 1303 with exchange of the sequence of six amino acid sequence Glu-Asn-Arg-Val-Asn-Asp to Arg-Glu-Ser-Cys-Glu followed by a stop codon. MutationTaster classifies this variant as pathogenic. According to ACMG guidelines, the variant c.3905dupT classified as pathogenic. Classification according to ACMG guidelines: PVS1: reading frame shift with stop mutation in a gene for which pathogenic new mutations are known to cause disease for Rubinstein-Taybi syndrome. PM1: The variant is particularly close to 18 other pathogenic variants. PM2: The variant was not found in any population genetic studies (such as GnomAD, Iranome, GME, 1kGP, etc.) identified. PS2: Potential new mutation (pending independent validation). PP3: Bioinformatic prediction programs classify this variant as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000750" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0002902" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000028" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000452" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0007678" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001252" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001629" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0006315" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0011451" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000486" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EP300">
              <Name>E1A binding protein p300</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_001429.4:exon 24</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001429.4:c.3905dupT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613684" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7334053</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2637928" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000028" MappingRef="HP">
        <MedGen CUI="C0010417" Name="Cryptorchidism" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2637928" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002902" MappingRef="HP">
        <MedGen CUI="C0020625" Name="Hyponatremia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2637928" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001629" MappingRef="HP">
        <MedGen CUI="C0018818" Name="Ventricular septal defect" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2637928" TraitType="Finding" MappingType="XRef" MappingValue="HP:0011451" MappingRef="HP">
        <MedGen CUI="C2677180" Name="Primary microcephaly" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2637928" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001252" MappingRef="HP">
        <MedGen CUI="C0026827" Name="Hypotonia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2637928" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000750" MappingRef="HP">
        <MedGen CUI="C0454644" Name="Delayed speech and language development" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2637928" TraitType="Disease" MappingType="XRef" MappingValue="613684" MappingRef="OMIM">
        <MedGen CUI="C3150941" Name="Rubinstein-Taybi syndrome due to EP300 haploinsufficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2637928" TraitType="Finding" MappingType="XRef" MappingValue="HP:0007678" MappingRef="HP">
        <MedGen CUI="C0238300" Name="Lacrimal duct stenosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2637928" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000486" MappingRef="HP">
        <MedGen CUI="C0038379" Name="Strabismus" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2637928" TraitType="Finding" MappingType="XRef" MappingValue="HP:0006315" MappingRef="HP">
        <MedGen CUI="C1840235" Name="Solitary median maxillary central incisor syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2637928" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000452" MappingRef="HP">
        <MedGen CUI="C0584837" Name="Choanal stenosis" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

